
usd may pm et
summari largest distributor health care product servic
office-bas dental medic practition
price-to-earnings oper ep
past perform indic futur perform reli upon
analysi prepar equiti analyst
may pm stock trade
revenu grew slower yoy
neg impact dental
practic global due offic closur
start mid china later
quarter europ dental sale
total drop yoy mainli
driven sharp declin
intern segment total
dental sale revenu declin limit
quarter total yoy
januari februari signific
disrupt start march expect
continu due social distanc
medic sale total yoy
thank strong growth sale
total yoy due consider
increas ppe order march januari
februari rel in-lin
servic includ corpor total
yoy due posit recur
expect ep drop yoy due
declin global dental sale due
pandem expect downtrend dental
sale amplifi see
full quarter impact dental practic closur
think posit long-term
competit yet strongli challeng
due pandem
neg impact alreadi slow grow
view largest medic dental
practic wholesal global durabl
posit dental medic practic suppli
two market think see long-term
growth see alreadi reflect
valuat dental medic segment
benefit two favor long-term
trend view includ age
util develop market gradual
shift health care deliveri toward lower cost
non-acut outpati facil
price target ep
estim histor forward price-to-earnings
averag due declin global dental sale
due pandem risk see
faster anticip dental sale declin
durat depth
pandem increas beyond expect
potenti market share loss web-bas
risk assess reflect histori consist
revenu growth everi year sinc steadili
grown market share dental medic practic
suppli busi think benefit
integr practic manag softwar product
distribut busi balanc
increas depend acquisit sustain
earn growth particularli organ growth dental
consum slow recent year also face
risk low cost e-commerc compani enter
market sell commodit dental medic practic
suppli view
aug ep estim base cfra oper earn
histor earn report compani report
past perform indic futur perform
reli upon
forecast reliabl indic futur perform
stk
redistribut reproduct prohibit without written permiss copyright cfra document intend provid person invest advic take account specif invest
object financi situat particular need specif person may receiv report investor seek independ financi advic regard suitabl and/or appropri make
invest implement invest strategi discuss document understand statement regard futur prospect may realiz investor note incom
invest may fluctuat valu invest may rise fall accordingli investor may receiv back less origin invest investor seek advic concern impact
invest may person tax posit tax advisor pleas note public date document may contain specif inform longer current use make
invest decis unless otherwis indic intent updat document
vice-president corpor financ
corpor overview largest distributor health care product servic
office-bas health care practition compani suppli dental physician practic
suppli might need dental hand piec exam glove x-ray machin compani also
hsic primari busi distribut segment account revenu
oper profit distribut includ dental product gener total sale
medic product total revenu gener remaind
technolog segment primarili sell practic manag softwar dental medic practic
account revenu oper profit technolog segment achiev
oper profit margin significantli higher margin achiev
distribut segment
market profil health care product distribut industri relat office-bas
practition encompass dental anim health medic market due part inabl
store manag larg quantiti suppli offic distribut health care suppli
small equip office-bas practition character frequent small quantiti order
need rapid reliabl order fulfil
industri continu experi growth due age popul util health care servic
frequent prolifer medic technolog amongst expand global middl class
increas health dental insur coverag addit physician market continu benefit
shift procedur diagnost test acute-car set alternate-car site
recent year seen health care industri increasingli focus cost contain
fuel growth hmo group practic collect buy group addit emphasi
obtain product competit price collabor tend favor distributor capabl
provid special manag inform support trend benefit distributor
provid broad array product low price technolog solut improv care deliveri
also led mani distributor limit financi oper market resourc combin
larger compani provid growth opportun
competit landscap compet highli fragment custom base
distributor well sever manufactur dental medic product sell direct
end-us primari competit factor industri price breadth product line custom
servic market scale value-ad servic on-cal repair fleet practic manag
sale dental product primari competitor patterson benco dental suppli
primari competitor sale medic product medlin
corpor strategi track record deploy capit mainli share
repurchas sought continu expand product servic offer domest
intern acquisit dental medic product distributor smaller scale
anim health spin-off first announc april complet februari along
plan merg spin-off vet first choic form independ public compani vet first
choic current provid technology-en solut prescript manag softwar
veterinari practition part transact receiv tax-fre dividend billion
aim creat sharehold valu share repurchas incept
repurchas program june decemb repurchas total
share avail futur repurchas howev expect halt compani
share buy-back program remaind expect hold cash
crisi deepen
impact major develop announc march new rapid blood
test avail distribut detect standard igm/igg test
manufactur south korean compani sd biosensor inc deliv result within minut
administ point care interest caveat test need fda
clearanc serolog test identifi antibodi assess likelihood current past
infect thu test distribut quickli march avail
increas begin april howev fda recommend blood test follow
molecular diagnost confirm limit sole reliabl test result view
financi trend total revenu decreas billion billion
repres three-year neg compound annual growth rate compound-annual-growth-rate start februari
contribut anim health busi total revenu longer
includ explain part revenu declin moreov despit frequent bolt-on acquisit
period dental sale slowli grow yoy adjust pre-tax incom per share account
cost hsic acquisit increas three-year compound-annual-growth-rate
thank mainli consist share buyback decreas share count view hsic balanc sheet
leverag posit favor oper incom cover net interest expens healthi
net debt/ebitda low conserv leverag level leav solid liquid
posit view particularli shock intensifi
redistribut reproduct prohibit without prior written permiss copyright cfra
base cfra proprietari quantit model
stock rank overvalu
analysi stock current worth base
cfra proprietari quantit model suggest
fairli valu
neutral sinc april technic indic
neutral
figur base fiscal year-end price
growth rate averag
lt debt capit
return equiti
balanc sheet data million usd
oper
long term debt capit
net incom revenu
return asset
return equiti
 global market intellig data may preliminari restat result discontinu operations/speci item per share data adjust stock dividend ep dilut
redistribut reproduct prohibit without prior written permiss copyright cfra
fundament outlook health care
distributor sub-industri posit
despit number headwind stem
pharmaceut distribut
rel well-plac current
environ expect major chang
demand prescript drug even
recess often necess
demand inelast view
hand see exponenti surg
demand person protect equip ppe
 global
number health care distributor
see distribut revenu bolster
growth prescript volum slowdown
brand drug patent expir
neg side expect profit margin
see continu pressur consolid
drug suppli chain focu mainli
drug distribut busi gener
sub-industri revenu
prescript drug demand continu
increas turn drive
greater volum handl distributor
driven view age
babi boomer prime util year
gain health-insur popul
accord latest censu data
age cohort grow five time fast
total popul expect age
drive long-term growth prescript drug
demand senior tend health care
need younger cohort
along rise prescript volum
distributor tend benefit higher
price brand drug gener
expect brand support favor
period low patent expir year
ahead data evaluatepharma indic
annual global drug sale risk expir
patent averag total
clear way substanti
amount lower-pr gener enter
market expir forecast drop
howev
posit brand drive
higher revenu distributor
typic collect percentag drug price
exchang manufactur
pharmaci exchang wareh
ship data track servic yet
longer term think brand drug price face
risk new regul politician
increasingli focus control voter drug
cost see outlook pharmaceut
immedi concern distributor
view grow scale player
drug suppli chain consolid drug
maker upstream well pbm manag
care firm provid downstream
on-going
consolid increas negoti power
supplier custom distributor
limit abil improv oper margin
posit correl recent
year health
distributor index tend move
direct year date april
health distributor index
decreas compar
decreas experienc broader
healthcar sector decreas
overal index
health distributor index
increas line rise
healthcar sector rise
 index
base index
five-year market price perform may
note sector sub-industri inform base
past perform indic futur perform
reli upon
yield equiti
ltd
peer group compani stock select issu base market capit
note peer select base global industri classif standard market capit peer group list includ compani similar characterist may includ compani within
industri and/or engag line busi
redistribut reproduct prohibit without prior written permiss copyright cfra
pm et cfra maintain hold opinion share inc
lift target ep estim initi
-- histor forward price-to-earnings averag due stagnant dental sale
maintain ep estim ep vs beat
consensu revenu grew yoy slower yoy
exclud impact acquisit dental revenu total grew yoy
flat exclud acquisit medic grew healthi yoy
dental sale growth lacklust sever year view
think medic experienc strong demand growth health care provid shift
care medic offic ambulatori center serv also
think strong posit practic manag softwar help deliv solid
organ growth technolog segment yoy continu
gain market share view think busi strength alreadi fairli
reflect peer valuat /colin scarola
et cfra maintain hold opinion share inc
lower target ep estim --
histor forward price-to-earnings averag due weaken intern demand
maintain ep estim ep vs beat
consensu sale grew yoy mix result across segment
dental sale total drop yoy flat sale north america
declin medic sale grew yoy
boost medic organ growth yoy think
reflect shift demand toward non-acut facil suppli
away higher-cost hospit care pre-tax incom per share adjust
anim spin-off grew yoy faster revenu interest
materi lower reduc debt yoy proce spin-off
view balanc sheet healthi expect bolt-on
throughout bolster organ growth current see share
analyst research note compani news
pm et cfra maintain hold opinion share inc
cut target ep estim
hsic histor forward price-to-earnings averag declin global dental sale
stem reduc patient traffic due lower
ep estim ep estim
ep vs estim
consensu revenu grew slower yoy neg
impact dental practic global start mid dental sale
total drop yoy mainli driven declin
intern segment total dental revenu declin
limit total yoy practic oper mostli line
januari februari medic sale total yoy due
consider increas ppe order march januari februari
expect technolog value-ad servic includ corpor
total yoy due posit recur revenu trend /sel
et cfra keep hold opinion share inc
announc yesterday new rapid blood test
avail distribut detect standard igm/igg
rapid test manufactur south korean compani sd biosensor inc
deliv result within minut administ point
care interest caveat test need fda clearanc
serolog test identifi antibodi assess likelihood
current past infect thu test distribut quickli
march avail increas begin april
howev fda recommend blood test follow molecular
diagnost confirm limit sole reliabl test
result view retain hold opinion think posit
price news limit posit impact share
yesterday intra-day follow news bounc back
shortli /sel hardi
et cfra maintain hold opinion share inc
keep target price ep estim
hsic histor forward price-to-earnings averag due stagnant dental sale
maintain ep estim ep estim
ep vs yoy beat capit iq consensu
revenu grew yoy driven strong medic total
yoy technolog value-ad servic total yoy
offset lacklust growth dental sale total yoy due
slow growth north american intern sale particular drop sale
dental consum merchandis expect revenu grow
ep includ share repurchas author left
view largest medic dental practic wholesal global
durabl posit dental medic practic suppli two market
think see long-term growth see alreadi reflect valuat
remain neutral share /sel hardi
pm et cfra maintain hold opinion share inc
lower target price ep estim
histor forward price-to-earnings averag due stagnant dental sale
fundament view stock unchang maintain ep estim
lower target reflect deterior investor sentiment follow
news last week hsic contract loss pacif dental view
contract loss insignific make less
compani project world-wide sale dental sale growth
slow sever year view medic experienc strong
demand growth health care provid shift care medic offic
ambulatori center serv also think strong posit
practic manag softwar help deliv solid organ growth
technolog segment yoy continu gain market share
view busi strength fairli reflect peer
note research note reflect cfra publish opinion analysi stock time note publish note reflect view equiti analyst date time
indic note may reflect cfra current view compani
redistribut reproduct prohibit without prior written permiss copyright cfra
fiscal year analyst estim earn
usd quarter fiscal year
announc earn per share usd repres
total revenu estim fiscal year
analyst estim earn per share grow
usd
total
estimate
forecast reliabl indic futur perform
note compani earn outlook play major part invest decis global market intellig organ earn estim wall street analyst
provid consensu earn next two year well earn estim chang time note inform provid relat consensu
estim intend predict actual result taken reliabl indic futur perform
note tabl graph chart report cite refer sourc sourc global market intellig
redistribut reproduct prohibit without prior written permiss copyright cfra
sinc januari cfra equiti fund research servic
predecessor capit iq equiti research rank univers
common stock adr american depositari receipt adss american
depositari share base given equiti potenti futur perform
similarli rank asian european equiti sinc june
rank equiti accord individu forecast equiti futur total
return potenti versu expect total return relev benchmark
region index asia europ
base time horizon star design meet need
investor look put invest decis perspect data use
assist determin star rank may result analyst
model well intern proprietari model result dynam data
also known
 growth
stabil earn dividend deem key element establish
global market intellig earn dividend rank common stock
design capsul natur record singl symbol
note howev process also take consider certain
adjust modif deem desir establish rank
final score stock measur score matrix determin
analysi score larg repres sampl stock
rang score array sampl align follow
ladder rank
cfra earn per share ep estim reflect analyst project futur
ep continu oper gener exclud variou item
view special non-recur extraordinari also ep estim reflect
either forecast equiti analyst consensu averag ep estim
independ compil global market intellig data
provid cfra among item typic exclud ep estim
asset sale gain impair restructur merger-rel charg legal
insur settlement process research develop expens gain
loss extinguish debt cumul effect account
chang earn relat oper classifi
compani discontinu inclus item stock option
expens recur type charg may vari depend
factor industri practic analyst judgment extent
type data disclos compani
equiti analyst project market price given secur command
month henc base combin intrins rel privat
cfra equiti research produc distribut account research
analyt llc d/b/a cfra cfra us togeth affili
subsidiari cfra certain research produc distribut cfra
sdn bhd compani formerli known standard poor
malaysia sdn bhd cfra malaysia certain research distribut cfra uk
limit cfra uk cfra uk cfra malaysia wholly-own subsidiari
cfra us
abbrevi use equiti research report
ebit earn interest tax
p/nav price net asset valu ratio price-to-earnings-to-growth ratio pv present
 research develop roce return capit employ roe
return equiti
roi return invest
 return invest capit
roa return asset
wacc weight averag capit
dividend american depositori receipt adr american depositori
share adss net tax paid countri origin
reflect equiti analyst view given compani oper risk
risk firm abil continu on-going concern qualit risk
assess rel rank star univers
reflect risk factor relat compani oper oppos risk
volatil measur associ share price etf reflect
capitalization-weight basi averag qualit risk assess
assign hold fund
star rank system definit
total return expect outperform total return relev benchmark
notabl margin come month share rise price
total return expect outperform total return relev benchmark
come month share rise price absolut basi
total return expect close approxim total return relev
benchmark come month share gener rise price
absolut basi
total return expect under-perform total return relev
benchmark come month share price anticip
total return expect under-perform total return relev
benchmark notabl margin come month share fall
price absolut basi
north america relev benchmark europ
asia relev benchmark europ asia
redistribut reproduct prohibit without prior written permiss copyright cfra
